With 1.29 million shares changed hands, the volume of the stock remained heavier than its average volume of 73610.0 shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $10.68 whereas the lowest price it dropped to was $9.8. The 52-week range on TLX shows that it touched its highest point at $30.36 and its lowest point at $10.50 during that stretch. It currently has a 1-year price target of $18.44.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TLX was down-trending over the past week, with a drop of -16.05%, but this was down by -24.81% over a month. Three-month performance dropped to -38.22% while six-month performance fell -46.30%. A look at the trailing 12-month EPS for TLX yields 0.03 with Next year EPS estimates of 0.33. For the next quarter, that number is 0.05. This implies an EPS growth rate of 31.40% for this year and 174.30% for next year.
Float and Shares Shorts:
On 2025-08-15, short shares totaled 19552.0, which was 1.0 higher than short shares on 1752537600. In addition to Dr. Christian P. Behrenbruch BEng(Hons), DPhil(Oxon), GAICD, J.D., M.B.A., MBA as the firm’s Co-Founder, MD, Group CEO & Executive Director, Mr. Darren Smith B.Bus., FCPA, M.B.A. serves as its Group Chief Financial Officer.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With TLX analysts setting a high price target of 23.651342 and a low target of 22.158504, the average target price over the next 12 months is 22.898928. Based on these targets, TLX could surge 133.02% to reach the target high and rise by 118.31% to reach the target low. Reaching the average price target will result in a growth of 125.61% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.20808 being high and $0.1156 being low. For TLX, this leads to a yearly average estimate of $0.15028. Based on analyst estimates, the high estimate for the next quarter is $0.09 and the low estimate is $0.09. The average estimate for the next quarter is thus $0.09.
